ascopubs.org

Direct comparative and network meta analysis of PARP inhibitor and androgen receptor targeted therapies in first line mCRPC: Defining the optimal regimen among 8,997 patients.

Influence of body composition on the efficacy of chemotherapy in men with metastatic aggressive variant prostate cancer (AVPC). Overall survival in men with metastatic castration-resistant prostate ...
Medscape

IV Dexamethasone Ranks Best Against Post-Block Rebound Pain

A new analysis ranks intravenous administration of dexamethasone as the most effective approach to prevent rebound pain after ...
ascopubs.org

Network meta-analysis of second- and later-line therapies in advanced renal cell carcinoma: A comparative effectiveness approach.

First results of a dose-escalation study evaluating Clostridium butyricum MIYAIRI 588 (CBM588) with nivolumab/ipilimumab (nivo/ipi) in metastatic renal cell carcinoma (mRCC). This is an ASCO Meeting ...